Purchase Order HT001424P0252
Award Date
9/20/24
Potential Completion Date
9/25/24
Potential Value
$139K
Federal Agency
Defense Health Agency
Awardee
Biotheranostics Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $139,428.00 firm fixed price purchase order was awarded by the Defense Health Agency (DHA) to Biotheranostics Inc., a self-certified small disadvantaged business. The contract is for the provision of Biotheranostics' proprietary Breast Cancer Index genomic diagnostic testing services to support cancer care for the DHA's beneficiary population. This contract award represents one of several prime federal awards, totaling over $700,000 between 2021-2023, that Biotheranostics has received...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Biotheranostics Inc., a self-certified small disadvantaged business, to provide Breast Cancer Index testing services for the Walter Reed National Military Medical Center. The $96,825 contract does not have a set-aside designation. Biotheranostics specializes in providing genomic diagnostic testing to support precision oncology and has been awarded multiple federal contracts by the Department of Veterans...
This firm-fixed-price purchase order was awarded to Biotheranostics Inc., a self-certified small disadvantaged business and division of Hologic, Inc. The $51,350 contract provides cancer identification testing services to the Department of Veterans Affairs (VA). The work supports the VA's efforts to enhance cancer care for veterans through advanced molecular diagnostics that guide treatment planning. Biotheranostics specializes in genomic diagnostic testing, including its proprietary Breast...
This is a $256,599.00 firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Biotheranostics Inc., a self-certified small disadvantaged business and division of Hologic, Inc. The contract is for the provision of the Breast Cancer Index (BCI) diagnostic test. The BCI test leverages genomic analysis to aid in cancer screening, diagnosis, and treatment planning. This award is not set aside and is one of several prime federal...
This federal contract award to Genomic Health, Inc. is for the provision of breast cancer testing services to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The $125,000.00 Firm Fixed Price Blanket Purchase Agreement (BPA) contract does not utilize any set-aside designations and was awarded on September 21, 2016, with a completion date of September 20, 2017. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in genomic-based cancer...
The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of diagnostic testing supplies for cancer treatment. The potential value of the contract is $150,000.00, with a completion date of September 7, 2022. The contract was not set aside for any specific business type. Genomic Health has a history of providing cancer testing services, including its Oncotype DX portfolio of...
This federal contract award was issued by the Defense Health Agency (DHA) to Hologic Sales And Service, LLC, a division of Hologic, Inc., for the delivery of molecular testing supplies. The $613,487.50 firm-fixed-price contract is a blanket purchase agreement (BPA) call with a period of performance ending on July 30, 2025. There was no set-aside used for this award. Hologic Sales And Service is a prime contractor that has provided a variety of medical equipment, devices, reagents, and related...
The Defense Health Agency awarded a $145,066 firm fixed price blanket purchase agreement call contract to Genomic Health, Inc., a division of Exact Sciences Corporation, to deliver its Oncotype Portfolio of genomic tests for earlier cancer detection and cancer treatment. The testing portfolio aims to support the Defense Health Agency's efforts to advance cancer screening and personalized treatment selection. Performance will occur in Bethesda, Maryland over one year effective September 2023....
This is a delivery order awarded to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of Oncotype cancer testing services to the Defense Health Agency (DHA). The contract has a ceiling value of $124,588.79 and a period of performance from March 16, 2025, to March 15, 2026, with the testing to be performed at Nellis Air Force Base in Nevada. The contract is a firm fixed-price type and does not have a set-aside designation. Genomic Health, Inc. is a for-profit...
This is a firm fixed-price blanket purchase agreement (BPA) call awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX breast cancer testing services. The contract has an ultimate completion date of February 8, 2018 and a ceiling value of $10,361.88. Genomic Health, Inc. is a for-profit organization that specializes in advanced genetic testing services for federal healthcare systems. The company has been awarded several...